Success Metrics

Clinical Success Rate
73.7%

Based on 14 completed trials

Completion Rate
74%(14/19)
Active Trials
1(4%)
Results Posted
14%(2 trials)
Terminated
5(20%)

Phase Distribution

Ph phase_2
10
40%
Ph not_applicable
3
12%
Ph phase_1
1
4%
Ph phase_3
7
28%
Ph phase_4
2
8%
Ph early_phase_1
2
8%

Phase Distribution

3

Early Stage

10

Mid Stage

9

Late Stage

Phase Distribution25 total trials
Early Phase 1First-in-human
2(8.0%)
Phase 1Safety & dosage
1(4.0%)
Phase 2Efficacy & side effects
10(40.0%)
Phase 3Large-scale testing
7(28.0%)
Phase 4Post-market surveillance
2(8.0%)
N/ANon-phased studies
3(12.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

73.7%

14 of 19 finished

Non-Completion Rate

26.3%

5 ended early

Currently Active

1

trials recruiting

Total Trials

25

all time

Status Distribution
Active(1)
Completed(14)
Terminated(5)
Other(5)

Detailed Status

Completed14
Terminated5
unknown4
Active, not recruiting1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
25
Active
1
Success Rate
73.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (8.0%)
Phase 11 (4.0%)
Phase 210 (40.0%)
Phase 37 (28.0%)
Phase 42 (8.0%)
N/A3 (12.0%)

Trials by Status

completed1456%
terminated520%
active_not_recruiting14%
suspended14%
unknown416%

Recent Activity

Clinical Trials (25)

Showing 20 of 25 trialsScroll for more
NCT05562518Phase 4

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Active Not Recruiting
NCT02357472Not Applicable

The Effect of a Higher Dose of Dehydroepiandrosterone (DHEA) Supplementation in Poor Responders

Terminated
NCT02432248Not Applicable

Effect of DHEA on Patients With Poor Ovarian Responds

Unknown
NCT05900661Phase 2

The Effect of Myo-inositol, Somatropin, and DHEA on Poor Ovarian Responders

Unknown
NCT04066478Phase 2

Does DHEA IVF Outcomes in Poor Responders?

Suspended
NCT00607646Early Phase 1

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus

Completed
NCT01535872Phase 3

Study of Dehydroepiandrosterone Treatment for Poor Responders in In Vitro Fertilization Patients

Completed
NCT02794948Phase 1

Chinese Medicine(Hu Yang Yang Kun Formula) for Primary Ovarian Insufficiency

Completed
NCT00248989Phase 3

Effect of DHEA on Skin Aging in Postmenopausal Women

Completed
NCT00289926Phase 3

Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms

Completed
NCT01572025Phase 3

Dehydroepiandrosterone (DHEA) Intervention To Treat Ovarian Aging

Completed
NCT00650754Phase 2

Study of Oral Dehydroepiandrosterone(DHEA) to Treat Previously Unexplained Infertility

Terminated
NCT01129830Early Phase 1

The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve

Terminated
NCT00948857Phase 2

Dehydroepiandrosterone (DHEA) Treatment and Premature Ovarian Failure (POF)

Terminated
NCT00916396Not Applicable

Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder

Unknown
NCT00419913Phase 2

A Trial of Dehydroepiandrosterone (DHEA) Treatment for in Vitro Fertilization (IVF)

Terminated
NCT00001598Phase 2

DHEA Treatment for Sjogren's Syndrome

Completed
NCT00001487Phase 2

Treatment of Mid-Life-Related Mood Disorders

Completed
NCT00575341Phase 3

Dehydroepiandrosterone Substitution in Adolescent and Young Women With Central Adrenal Insufficiency

Completed
NCT00543166Phase 4

Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue

Unknown

Drug Details

Intervention Type
DRUG
Total Trials
25